[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:elafin":3},{"name":4,"total":5,"recruiting":6,"trials":7},"Elafin",1,0,[8],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07601295","Tiprelestat Versus Placebo When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension (PAH)",[12],"Phase 2","NOT_YET_RECRUITING","2026-08-26T02:18:32.765187Z","2026-05-29T15:36:40.220514Z"]